Castle Biosciences, Inc. (CSTL) vs Integra LifeSciences Holdings Corporation (IART)

A side-by-side comparison of Castle Biosciences, Inc. and Integra LifeSciences Holdings Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CSTL vs IART

growth of $100 · dividends reinvested · last 7y
CSTL +71.3% (+8.0%/yr)IART -79.0% (-20.0%/yr)CSTL compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120232025$171$21
CSTL IART

CSTL vs IART: by the numbers

  • •CSTL is the larger company ($1.11B vs $1.00B market cap).
  • •Both run net losses; IART's is the smaller (-0.44% vs -5.43% net margin).
  • •CSTL grew revenue faster over the past five years (35.55% vs 1.77% CAGR).

Metrics side by side

Valuation

MetricCSTLIART
Forward P/EN/A5.29
P/S ratio3.100.61
P/B ratio2.360.96
EV / EBITDAN/A3.50

Profitability

MetricCSTLIART
Gross margin77.26%53.74%
Operating margin-8.99%4.18%
Net margin-5.43%-0.44%
ROE-4.13%-0.69%
ROIC-6.33%20.01%

Growth (annualized)

MetricCSTLIART
Revenue CAGR (5Y)35.55%1.77%
Total return CAGR (5Y)-10.28%-28.16%

Frequently asked

Which has grown faster, CSTL or IART?
Over the past five years, CSTL grew revenue faster — CSTL at a 35.55% CAGR versus IART at 1.77%.
How have CSTL and IART total returns compared?
Over the past 5 years, CSTL delivered -10.28% and IART delivered -28.16% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.